817.89MMarket Cap-7742P/E (TTM)
7.570High7.100Low281.97KVolume7.570Open7.590Pre Close2.04MTurnover0.32%Turnover RatioLossP/E (Static)114.07MShares10.24052wk High1.61P/B632.75MFloat Cap1.61052wk Low--Dividend TTM88.25MShs Float106.340Historical High--Div YieldTTM6.19%Amplitude1.610Historical Low7.250Avg Price1Lot Size
Mesoblast Stock Forum
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Gregory George(15.27%),G to the Fourth Investments, LLC(4.48%), etc.
Mesoblast (MESO) has released an update.
Mesoblast Limited has reported significant progress in its discussions with the FDA, receiving guidance on licensure paths for its innovative therapies, remestemcel-L for pediatric graft versus host disease, and rexlemestrocel-L for end-stage heart failure. The company is poised to resubmit its Biologics License Application for remestemcel-L and seeks an accelerated approval for ...
No comment yet